A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

Clinical trial NCT01537705 · UNKNOWN

Trial details

NCT number: NCT01537705
Sponsor: Targeted Medical Pharma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Neuropathy Chemotherapy Induced Neuropathy HIV Neuropathy Trauma Induced Neuropathy

Start date: 2012-03-01
Primary completion: 2012-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.